Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 10Prostatic Neoplasms 8Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Glioblastoma 4Urinary Bladder Neoplasms 3Sarcoma 3Oropharyngeal Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Kidney Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Neoplasm Metastasis 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Glioma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Astrocytoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Anal Canal 1

Interventions

Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Endometrial Serous Adenocarcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
4 enrolled 6 charts
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡